Localization dose and time of antigens determine immune reactivity

Seminars in Immunology

Volumn 12, Issue 3, 2000, Pages 163-171

  Zinkernagel, Rolf M ^a  

^a INSTITUTE OF EXPERIMENTAL IMMUNOLOGY   (Switzerland)

Author keywords

B cells; Coevolution; Deletion; Ignorance; Immune protection; Induction; Pattern recognition; T cells

Indexed keywords

ANTIGEN;

ANTIGEN RECOGNITION; B LYMPHOCYTE ACTIVATION; IMMUNOREACTIVITY; LYMPHOID ORGAN; REVIEW; T LYMPHOCYTE ACTIVATION;

EID: 0034210006     PISSN: 10445323     EISSN: None     Source Type: Journal    
DOI: 10.1006/smim.2000.0253     Document Type: Article

References (67)

1. Zinkernagel R M, Pircher H P, Ohashi P., Odermatt B., Mak T., Arnhelter H., Bürki K., Hengartner H. T and B cell tolerance and responses to viral antigens in transgenic mice: implications for the pathogenesis of autoimmune versus immunopathological disease. Immunol Rev. 122:1991.
2. Zinkenagel R M, Ehl S., Aichele P., Oehen S., Küdig T., Hengartner H. Antigen localisation regulates immune responses in a dose and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev. 156:1997.
3. Traub E. A filterable virus recovered from white mice. Science. 81:1935.
4. Billingham R E, Brent L., Medawar P B. Actively aquired tolerance of foreign cells. Nature. 172:1953.
5. Gershon R K, Kondo K. Infectious immunological tolerance. Immunology. 21:1971.
6. Jerne N K. Towards a network theory of the immune system. Ann Immunol (Paris). 125C:1974.
7. Bretscher P., Cohn M. A theory of self-nonself discrimination. Science. 169:1970.
8. Ridge J P, Fuchs E J, Matzinger P. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells [see comments]. Science. 271:1996.
9. Sarzotti M., Robbins D S, Hoffman P M. Induction of protective CTL responses in newborn mice by a murine retrovirus [see comments]. Science. 271:1996.
10. Forsthuber T., Yip H C, Lehmann P V. Induction of TH1 and TH2 immunity in neonatal mice [see comments]. Science. 271:1996.
11. Lafferty K J, Cunningham A J. A new analysis of allogeneic interactions. Aust J Exp Biol Med Sci. 53:1975.
12. Schwartz R H. A cell culture model for T lymphocyte clonal anergy. Science. 248:1990.
13. Schwartz R H. Models of T cell anergy: is there a common molecular mechanism? [comment]. J Exp Med. 184:1996.
14. Matzinger P. Tolerance, danger, and the extended family. Annu Rev Immunol. 12:1994.
15. Zinkernagel R M. Immunology taught by viruses. Science. 271:1996.
16. Bachmann M F, Zinkernagel R M. The influence of virus structure on antibody responses and virus serotype formation. Immunol Today. 12:1996.
17. Karrer U., Althage A., Odermatt B., Roberts C W M, Korsmeyer S J, Miyawaki S., Hengartner H., Zinkernagel R M. On the key role of secondary lymphoid organs in antiviral immune responses studied in alymphoplastic (alylaly) and spleenless (Hox11(-)/-) mutant mice. J Exp Med. 185:1997.
18. Ludewig B., Odermatt B., Landmann S., Hengartner H., Zinkernagel R M. Dendritic cells induce autoimmune diabetes and maintain disease via de novo formation of local lymphoid tissue. J Exp Med. 188:1998.
19. Ohashi P S, Oehan S., Buerki K., Pircher H P, Ohashi C T, Odermatt B., Malissen B., Zinkernagel R M, Hengartner H. Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice. Cell. 65:1991.
20. Ochsenbein A F, Klenerman P., Karrer U., Ludewig B., Pericin M., Hengartner H., Zinkernagel R M. Immune surveillance against a solid tumor fails because of immunological ignorance. Proc Natl Acad Sci USA. 96:1999.
21. Webb S., Morris C., Sprent J. Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity. Cell. 63:1990.
22. Moskophidis D., Lechner F., Pircher H P, Zinkernagel R M. Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells [published erratum appears in Nature 1993 Jul 15, 364(6434):262]. Nature. 362:1993.
23. Ehl S., Aichele P., Ramseler H., Barchet W., Hombach J., Pirchur H P, Hengartner H., Zinkernagel R M. Antigen persistence and time of T-cell tolerization determine the efficacy of tolerization protocols for prevention of skin graft rejection. Nat Med. 4:1998.
24. Möller G., Gronowicz E., Persson U., Coutinho A., Moller E., Hammarstrom L., Smith E. Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med. 143:1976.
25. Frey J R, Wenk P. Experimental studies on the pathogenesis of contact eczema in the guinea-pig. Int Arch Allergy. 11:1957.
26. Mackay C R. Immunological memory. Adv Immunol. 53:217-65:1993.
27. Bachmann M F, Kündig T M, Hengartner H., Zinkernagel R M. Protection against immunopathological consequences of a viral infection by activated but not resting cytotoxic T cells: T cell memory without "memory T cells"? Proc Natl Acad Sci USA. 94:1997.
28. Kundig T M, Bachmann M F, Oehen S., Hoffmann U W, Simard J J, Kalberer C P, Pircher H P, Ohashi P S, Hengartner H., Zinkernagel R M. On the role of antigen in maintaining cytotoxic T-cell memory. Proc Natl Acad Sci USA. 93:1996.
29. Westermann J., Bode U. Distribution of activated T cells migrating through the body: a matter of life and death. Immunol Today. 20:1999.
30. Kundig T M, Bachmann M F, DiPaolo C., Simard J J, Battegay M., Lother H., Gessner A., Kuhlcke K., Ohashi P S, Hengartner H. Fibroblasts as efficient antigen-presenting cells in lymphoid organs. Science. 268:1995.
31. Speiser D E, Miranda R., Zakarian A., Bachmann M F, McKall Faienza K J, Odermatt B., Hanahan D., Zinkernagel R M, Ohashi P S. Self antigens expressed by solid tumors do not efficiently stimulate naive or activated T cells: implications for immunotherapy. J Exp Med. 186:1997.
32. Prevost-Blondel A., Zimmermann C., Stemmer C., Klumburg P., Rosenthal F M, Pircher H P. Tumor-infiltrating lymphocytes exhibiting high ex vivo cytolytic activity fail to prevent murine melanoma tumor growth in vivo. J Immunol. 161:1998.
33. Baer G M, Cleary W F. A model in mice for the pathogenesis and treatment of rabies. J Infect Dis. 125:1972.
34. Stavenson P G, Hawke S., Bangham C R. Protection against influenza virus encephalitis by adoptive lymphocyte transfer. Virology. 232:1997.
35. Hausmann J., Hallensleben W., de la Torre J C, Pagenstecher A., Zimmermann C., Pircher H P, Stachell P. T cell ignorance in mice to Born disease virus can be overcome by peripheral expression of the viral nucleoprotein. Proc Natl Acad Sci USA. 96:1999.
36. Weigle W O. The immune response of rabbits tolerant to bovine serum albumin to the injection of other heterologous serum albumins. J Exp Med. 114:1961.
37. Freund J., Stern E R, Pisani T M. Isoallergic encephalomyelitis and radiculitis in guinea pigs after one injection of brain and mycobacteria in water-in-oil emulsion. J Immunol. 57:1947.
38. Kyburz D., Aichele P., Speiser D E, Hengartner H., Zinkernagel R M, Pircher H P. T cell immunity after a viral infection versus T cell tolerance induced by soluble viral peptides. Eur J Immunol. 23:1993.
39. Aichele P., Brduscha Riem K., Zinkernagel R M, Hengartner H., Pircher H P. T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med. 182:1995.
40. Guerder S., Matzinger P. Activation versus tolerance: a decision made by T helper cells. Cold Spring Harb Symp Quant Biol. 54 Pt 2:1989.
41. +T cells to cause immunopathology. J Exp Med. 187:1998.
42. Wick M., Dubey P., Koeppen H., Siegel C T, Fields P E, Chem L., Bluestone J A, Schreiber H. Antigenic cancer cells grow progressively in immune hosts without evidence of T cell exhaustion or systemic anergy. J Exp Med. 186:1997.
43. Bachmann M F, Rohrer U H, Kündig T M, Bürki K., Hengartner H., Zinkernagel R M. The influence of antigen organization on B cell responsiveness. Science. 262:1993.
44. Bachmann M F, Hengartner H., Zinkernagel R M. T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur J Immunol. 25:1995.
45. Millch D R. T- and B-cell recognition of hepatitis B viral antigens. Immunol Today. 9:1988.
46. Dintzis H M, Dintzis R Z, Vogelstein B. Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci USA. 73:1976.
47. Dintzis R Z, Okajlma M., Middleton M H, Greene G., Dintzis H M. The immunogenicity of soluble haptenated polymers is determined by molecular mass and hapten valence. J Immunol. 143:1989.
48. Fehr T., Bachmann M F, Bucher E., Kalinke U., Padova F E D, Lang A B, Hengartner H., Zinkernagel R M. Role repetitive antigen patterns for induction of antibodies against antibodies. J Exp Med. 185:1997.
49. Zinkernagel R M, Cooper S., Chambers J., Lazzarini R A, Hengartner H., Arnhelter H. Virus induced autoantibody response to a transgenic viral antigen. Nature. 344:1990.
50. Namazee D A, Bürki K. Clonal deletion of B lymphocytes in a transgenic mouse bearing anti-MHC class I antibody genes. Nature. 337:1989.
51. Goodnow C C, Crosbie J., Jorgensen H., Brink R A, Basten A. Induction of self-tolerance in mature peripheral B lymphocytes [see comments]. Nature. 342:1989.
52. Schwartz R H. Acquisition of immunologic self-tolerance. Cell. 57:1989.
53. Schwartz R H. Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell. 71:1992.
54. Roost H-P, Charan S., Zinkernagel R M. Analysis of the kinetics of antiviral memory T help in vivo: characterization of short-lived cross-reactive T help. Eur J Immunol. 20:1990.
55. Stone H B, Owings J C, Gey G O. Living grafts of endocrine glands. Calif West Med. 39:1933.
56. Summerlin W T, Brouthar C., Foanes R B, Payne R., Stutman O., Hayflick L., Good R A. Acceptance of phenotypically differing cultured skin in man and mice. Transplant Proc. 5:1973.
57. Lafferty K J, Prowse S J, Simeonovic C J, Warren H S. Immunobiology of tissue transplantation: a return to the passenger leukocyte concept. Annu Rev Immunol. 1:143-73:1983.
58. Carbone F R, Kurts C., Bennett S R, Miller J F, Health W R. Cross-presentation: a general mechanism for CTL immunity and tolerance. Immunol Today. 19:1998.
59. Sigal L J, Crotty S., Andino R., Rock K L. Cytotoxic T-cell immunity to virus-infected non-haematopoietic cells requires presentation of exogenous antigen [see comments]. Nature. 368:1999.
60. Ganss R., Limmer A., Sacher T., Arnold B., Hammerling G J. Autoaggression and tumor rejection: it takes more than self-specific T-cell activation. Immunol Rev. 169:263-72:1999.
61. Alferink J., Aigner S., Reibke R., Hammerling G J, Arnold B. Peripheral T-cell tolerance: the contribution of permissive T-cell migration into parenchymal tissues of the neonate. Immunol Rev. 169:255-61:1999.
62. +T- helper and a T-killer cell. Nature. 393:1998.
63. Bennett S R, Carbone F R, Karamalis F., Flavell R A, Miller J F, Heath W R. Help for cytotoxic-T-cell responses is mediated by CD-40 signalling. Nature. 393:1998.
64. +T cell functions. J Exp Med. 183:1996.
65. Pardoll D M. Cancer vaccines. Nat Med. 4:1998.
66. Bevan M J. Antigen recognition. Class discriminiation in the world of immunology. Nature. 325:1987.
67. Albert M L, Sauter B., Bhardwaj N. Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature. 392:1998.